felin
coronaviru
fcov
common
pathogen
cat
envelop
positivesens
singlestrand
rna
viru
togeth
canin
coronaviru
ccov
transmiss
gastroenter
viru
tgev
porcin
respiratori
coronaviru
human
coronaviru
hcov
fcov
classifi
genu
alphacoronaviru
two
pathotyp
fcov
well
demonstr
ie
felin
enter
coronaviru
fecv
felin
infecti
periton
fip
viru
fipv
former
caus
mild
enter
infect
latter
caus
fatal
immunemedi
diseas
known
fip
infect
coronaviru
determin
interact
receptor
bind
domain
spike
protein
correspond
receptor
target
cell
protein
main
determin
cell
tropism
induct
neutral
antibodi
fcov
divid
two
serotyp
type
ii
differ
neutral
antibodi
reaction
distinct
protein
sequenc
two
type
fcov
differ
growth
characterist
vitro
type
ii
fcov
antigen
relat
ccov
tgev
receptor
usag
two
type
fcov
differ
felin
aminopeptidas
n
identifi
receptor
type
ii
fcov
type
fcov
main
receptor
type
fcov
infect
remain
unclear
felin
dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrin
serv
coreceptor
type
ii
fcov
type
fcov
infect
domest
wild
felida
caus
fip
seropreval
studi
detect
two
type
fcov
infect
perform
use
variou
method
type
fcov
found
predomin
field
seroposit
rate
wherea
type
ii
viru
account
less
infect
studi
typespecif
partial
proteinbas
immunofluoresc
assay
ifa
establish
distinguish
two
serotyp
fcov
seropreval
fcov
taiwan
determin
correl
genotyp
serotyp
fcov
infect
assess
cultiv
purif
titrat
recombin
baculoviru
rviru
spodoptera
cell
use
studi
cell
cultur
suspens
densiti
rang
cellsml
hyq
sfxinsect
media
hyclon
logan
ut
usa
contain
vv
fetal
bovin
serum
fb
paa
laboratori
gmbh
pasch
austria
gentamicin
feli
catu
whole
cell
use
propag
type
ii
fcov
strain
maintain
dulbecco
modifi
eagl
medium
gibco
grand
island
usa
supplement
fb
iuml
penicillin
streptomycin
sever
sampl
collect
cat
enrol
studi
includ
whole
blood
plasma
swab
sampl
rectal
nasal
oral
conjunctiv
swab
bodi
effus
intern
organ
sampl
screen
fcov
revers
transcriptionnest
polymeras
chain
reaction
rtnpcr
fcovposit
sampl
subsequ
subject
genotyp
viru
accord
procedur
report
addi
et
al
character
correl
serotyp
infect
fip
plasma
sampl
patholog
confirm
natur
occur
fip
case
suspect
fip
case
fcov
rtnpcr
posit
effus
withwithout
ifa
signal
present
macrophag
test
moreov
evalu
seropreval
differ
type
fcov
infect
taiwan
plasma
sampl
clinic
healthi
cat
collect
around
island
taiwan
sampl
store
analysi
ethic
approv
requir
studi
perform
retrospect
sampl
diseas
anim
routin
submit
veterinari
diagnost
laboratori
screen
antifcov
antibodyposit
sampl
type
ii
fcovbas
ifa
use
present
studi
cell
seed
plate
infect
type
ii
fcov
strain
multipl
infect
moi
incub
hour
well
contain
infect
cell
uninfect
cell
intern
neg
control
infect
cell
fix
cold
acetonemethanol
vv
ten
minut
plasma
sampl
dilut
pb
transfer
well
allow
incub
minut
room
temperatur
subsequ
cell
wash
time
pb
fluorescein
isothiocyan
fitc
conjug
goat
anticat
igg
dilut
ad
well
incub
room
temperatur
syncyti
cell
typic
cytopath
effect
cpe
fcov
infect
show
fluoresc
signal
interpret
posit
cat
consid
infect
fcov
posit
sampl
serotyp
protein
key
determin
discrimin
serotyp
region
specif
two
type
fcov
chosen
analysi
type
fcov
strain
genbank
type
ii
fcov
strain
genbank
employ
studi
two
pair
primer
base
rbd
region
gene
restrict
site
design
fcovi
prbd
f
fcovi
prbd
r
fcovii
prbd
f
fcovii
prbd
r
use
amplifi
target
region
gene
region
nucleotid
length
type
ii
fcov
respect
amplifi
product
clone
ht
vector
use
bactobac
baculoviru
express
system
invitrogen
srl
milan
itali
follow
manufactur
instruct
fcovi
prbdbacmid
fcovii
prbdbacmid
use
transfect
cell
obtain
rvirus
rfcovi
rfcovii
contain
ntermin
histidin
tag
cell
infect
rfcovi
rfcovii
differ
moi
valu
cell
pellet
differ
postinfect
time
lyse
western
blot
analysi
express
recombin
protein
resolv
sdspage
transfer
pvdf
membran
membran
block
use
wv
nonfat
dri
milk
two
hour
room
temperatur
follow
incub
antihistidin
mous
monoclon
antibodi
mab
invitrogen
srl
milan
itali
room
temperatur
wash
pbstween
membran
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antibodi
jackson
immunoresearch
laboratori
pa
usa
membran
develop
tetramethylbenzidin
tmb
substrat
kirkegaard
perri
laboratori
md
usa
differenti
serotyp
infect
novel
typespecif
ifa
use
rfcovi
rfcovii
infect
cell
establish
cell
seed
plate
infect
either
rfcovi
rfcovii
moi
hour
incub
infect
cell
fix
cold
acetonemethanol
twofolddilut
plasma
sampl
cat
fip
cat
transfer
well
rfcovi
rfcovii
infect
cell
mock
infect
incub
minut
room
temperatur
wash
time
pb
fitcconjug
goat
anticat
igg
ad
well
minut
room
temperatur
fcovposit
sera
collect
cat
without
fip
dilut
appli
ifa
system
serotyp
analysi
two
polyclon
antisera
vmrd
pullman
wa
usa
type
ii
fcov
use
referenc
positivecontrol
sera
two
sera
specif
pathogenfre
spf
cat
use
negativecontrol
sera
serotyp
fcov
infect
identifi
base
rfcovi
rfcoviiinfect
cell
rrbdii
show
fluoresc
signal
ifa
stain
higher
plasma
sampl
cat
fip
sampl
healthi
cat
compar
assay
establish
studi
gold
standard
method
plasma
sampl
fip
confirm
anim
examin
nt
test
typespecif
ifa
heat
inactiv
plasma
sampl
dilut
fold
follow
two
fold
serial
dilut
fold
subsequ
dilut
sampl
mix
equal
volum
type
ii
fcov
strain
contain
incub
h
mixtur
inocul
onto
cell
monolay
well
micropl
day
reciproc
highest
dilut
antibodi
complet
inhibit
viral
cpe
format
express
virusneutr
titer
sampl
confirm
fip
case
suspect
fip
case
fcov
seroposit
addit
cat
fip
total
clinic
healthi
cat
collect
veterinari
hospit
citi
taiwan
year
enrol
studi
posit
fcov
overal
preval
fcov
taiwan
tabl
distinguish
serotyp
fcov
infect
novel
typespecif
ifa
establish
express
protein
fragment
antigen
distinct
type
ii
fcov
typespecif
region
gene
base
put
rbd
type
ii
fcov
correspond
region
type
fcov
select
express
region
locat
amino
acid
protein
type
ii
fcov
respect
figur
partial
gene
differ
type
fcov
amplifi
direct
clone
ht
vector
use
gener
rvirus
ie
rfcovi
rfcovii
recombin
protein
expect
size
approxim
kda
type
type
ii
fcov
identifi
figur
specif
typespecif
ifa
verifi
use
plasma
sampl
confirm
type
ii
fcovinfect
cat
spf
cat
recombin
protein
could
detect
antihistidin
mab
posit
signal
locat
cytoplasm
contrast
fluoresc
signal
observ
use
sera
spf
cat
figur
plasma
type
fcovinfect
cat
could
specif
react
rrbdi
rrbdii
vice
versa
use
plasma
sampl
dualli
fcovinfect
cat
fip
posit
signal
could
observ
type
rrbd
figur
base
data
specif
recombin
protein
confirm
valid
assay
serotyp
result
deriv
typespecif
ifa
compar
gold
standard
nt
plasma
sampl
fip
anim
bear
antibodi
rrbdii
found
possess
rel
high
nt
titer
type
ii
fcov
indic
type
ii
fipv
infect
hand
sampl
bear
antibodi
sole
rrbdi
show
bare
detect
nt
titer
type
ii
viru
indic
type
fipv
infect
tabl
result
show
serotyp
determin
typespecif
ifa
test
highli
agreeabl
nt
test
among
seroposit
cat
cat
antibodi
specif
rrbdi
wherea
antibodi
rrbdii
react
type
tabl
infect
serotyp
fcov
appear
domin
fip
nonfip
group
tabl
evalu
correl
serotyp
genotyp
infect
plasma
sampl
collect
type
ii
fcovinfect
cat
fip
analyz
comparison
result
deriv
serotyp
genotyp
serotyp
fcov
found
highli
agre
genotyp
case
cat
type
fip
antibodi
specif
rrbdi
except
three
cat
tabl
sole
type
iiinfect
cat
fip
four
cat
titer
specif
rrbdii
one
cat
possess
antibodi
rrbdi
well
tabl
cat
without
fip
type
fcov
detect
rtnpcr
antibodi
rrbdi
posit
antibodi
type
addit
serotyp
four
sampl
fail
identifi
moreov
three
plasma
sampl
collect
healthi
cat
type
ii
fcov
detect
fecal
sampl
use
serotyp
three
sampl
fcov
seroposit
one
identifi
infect
type
fcov
cat
infect
fcov
fail
genotyp
possess
antibodi
type
fcov
tabl
studi
fcov
typespecif
recombin
proteinbas
ifa
establish
express
recombin
rbd
region
type
ii
fcov
protein
bear
onetenth
authent
protein
critic
viru
neutral
cell
attach
highli
conserv
among
fcov
tgev
ccov
align
amino
acid
sequenc
region
reveal
rel
conserv
among
prototyp
viral
strain
within
serotyp
ie
type
ii
fcov
respect
distinct
differ
serotyp
figur
express
partial
protein
contain
four
nlink
glycosyl
site
type
type
ii
fcov
figur
baculoviru
express
system
chosen
provid
posttransl
modif
complex
fold
includ
glycosyl
similar
strategi
appli
sever
acut
respiratori
syndrom
sar
cov
recombin
rbd
maintain
authent
antigen
induc
strong
rbdspecif
antibodi
respons
addit
baculovirusexpress
truncat
sarscov
proteinbas
ifa
found
highli
sensit
specif
compar
convent
whole
virusbas
ifa
base
differ
test
method
preval
fcov
field
cat
vari
among
countri
eg
switzerland
australia
japan
korea
present
studi
fcovspecif
antibodi
detect
ifa
base
protein
deriv
local
fcov
isol
reveal
seropreval
previou
studi
reveal
seroposit
cat
suspect
infect
type
fcov
present
studi
local
cat
infect
type
fcov
infect
type
ii
fcov
taiwan
higher
countri
ie
switzerland
japan
respect
dens
popul
close
contact
cat
anim
taiwan
could
reason
contribut
higher
rate
recombin
fcov
ccov
alphacoronavirus
lead
rel
high
type
ii
fcov
infect
rate
rel
high
antibodi
titer
type
ii
viru
might
also
result
alphacoronaviru
infect
felin
cell
suscept
infect
fcov
ccov
tgev
given
seroconvers
observ
cat
experiment
infect
ccov
tgev
prior
studi
competit
elisa
use
discrimin
serotyp
infect
howev
certain
sera
could
type
inhibit
reach
present
studi
serotyp
determin
direct
observ
fluoresc
signal
specif
indic
two
type
recombin
protein
decreas
ambigu
anoth
ifa
studi
use
type
type
ii
fcovinfect
cell
cat
display
equal
titer
type
ii
fcov
phenomenon
suggest
author
result
either
antibodi
common
antigen
epitop
structur
protein
coinfect
two
virus
typespecif
proteinbas
ifa
avoid
share
common
antigen
coinfect
readili
identifi
first
report
correl
viral
infect
specif
antibodi
evok
compar
serotyp
genotyp
fcovinfect
anim
type
fcovinfect
cat
fip
harbor
antityp
fcov
antibodi
three
display
antibodi
type
fcov
indic
coinfect
fcov
andor
cov
addit
one
cat
type
ii
fip
display
antibodi
respons
type
ii
fcov
simultan
find
match
recombin
theori
state
type
ii
fcov
aris
mutat
type
fcov
howev
found
three
cat
type
ii
fip
possess
antibodi
sole
type
ii
fcov
among
cat
cat
live
shelter
experienc
recent
fip
outbreak
caus
type
ii
fcov
presenc
antibodi
sole
type
ii
fcov
cat
provid
addit
clue
horizont
transmiss
type
ii
fip
case
cat
sequenc
analysi
ctermin
onethird
viral
genom
indic
viru
bear
high
resembl
ccov
fcov
combin
serolog
genet
find
fip
could
result
ccov
infect
genet
analysi
regard
specul
current
investig
among
healthi
cat
untyp
fcov
found
type
fcov
infect
although
serotyp
antibodi
detect
alway
match
viru
present
time
sampl
infect
fcov
especi
type
persist
last
sever
year
multicat
environ
moreov
type
viru
report
genet
divers
type
ii
viru
genotyp
region
divers
might
hinder
pcr
amplif
despit
better
distinguish
cat
current
studi
possess
antifcov
antibodi
could
serotyp
issu
could
due
lower
antibodi
titer
fcov
polymorph
may
exist
target
region
protein
fcov
antibodi
titer
accur
perform
thought
valu
distinguish
enter
infect
fip
cat
ifa
titer
highli
suggest
fip
studi
use
serotyp
method
establish
typespecif
fcov
antibodi
could
titrat
titer
fip
cat
reach
rel
high
level
well
recent
studi
reveal
infect
serotyp
ii
fcov
correl
significantli
occurr
fip
also
horizont
transmiss
serotyp
ii
viru
clearli
demonstr
respons
fip
outbreak
continu
survey
antibodi
two
serotyp
fcov
especi
multicat
environ
could
help
identifi
invas
type
ii
fcov
henc
isol
anim
prevent
futur
fip
occurr
conclus
compar
result
previou
studi
present
rel
simpl
serotyp
method
discrimin
two
type
fcov
infect
base
method
type
fcov
found
predomin
compar
type
ii
taiwan
survey
also
provid
clue
support
evolut
horizont
transmiss
type
ii
fipv
epidemiolog
survey
also
provid
valuabl
inform
diseas
control
vaccin
develop
author
declar
compet
interest
ytw
perform
sampl
prepar
fcov
detect
genotyp
typespecif
ifa
develop
antifcov
antibodi
detect
serotyp
analysi
prepar
manuscript
llc
conceiv
studi
particip
studi
design
coordin
contribut
prepar
manuscript
chw
particip
studi
design
supervis
typespecif
ifa
develop
contribut
prepar
manuscript
author
read
approv
final
manuscript
